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Effect of Oxytocin Injection into Umbilical Vein for Management of Retained Placenta
evidences that manual removal of placenta may be a risk factor for infection 3 , post-partum endometritis and risk of increased bleeding by interfering with normal mechanism of placental separation. 2 Routine administration of oxytocin during the third stage hastens placental separation, reduces blood loss of delivery and decreases the chance of PPH by 40%. 2 Oxytocin is the first line agent because of the paucity of side effects compared with all other available agents. 5 Umbilical vein injection of saline solution with oxytocin might represent an important option for management of retained placenta. This relatively simple and affordable technique could be used either for first response before proceeding to manual removal if necessary or as the only response where manual removal is not feasible. 6 This procedure facilitates high concentration of oxytocin to the placental bed and uterine wall, resulting in uterine contraction and placental separation. 7 Intraumbilical vein injection (IUV) is inexpensive, non-surgical, non-aggressive, cheap and pharmacological method which may be included in the treatment of retained placenta before going to manual lysis of placenta. 8 Regarding retained placenta, findings from international studies and clinical researches showed that appropriate and adequate management during emergency can reduce the mortality and long term complications. As there are very few numbers of studies done on retained placenta in Bangladesh, we designed this experimental study to assess the effect of intraumbilical vein oxytocin in the management of retained placenta and to compare it to the risk of manual removal of placenta. A solution of 10 mL oxytocin diluted in 20 mL normal saline (0.9% sodium chloride) was injected into the umbilical vein in all patients of Group A after the umbilical cord was clamped distally. The umbilical vein injection was given over a period of 30 minutes and traction was avoided until there was evidence of placental separation. 9 Suprapubic pressure was applied while observing for evidence of placental separation. No other intervention was performed to cause placental separation until at least 15 minutes after administration of oxytocin. After expulsion of the placenta oxytocin was administered as indicated.
Materials and Methods
Comparison between the groups was done by chisquare test using the SPSS version 16.0. p values <0.05 were considered significant.
Results
Total 8501 obstetric patients were admitted during the study period. Among them, number of patients having retained placenta was 175 (2.05%). Out of 50 study subjects 32 (64%) patients presented at 38 weeks of pregnancy and 15 (30%) patients at 39 weeks. Majority of the patients (38, 76%) delivered babies at home. Only 8 (16%) patients delivered in DMCH. Delivery was conducted by dai or relatives in majority patients (38, 76%). About 62% patients were admitted with features of shock and 12 (24%) had PPH without shock.
After administration of intraumbilical vein injection (IUV) of oxytocin in patients of Group A, placenta was delivered in 16 (80%) cases. Four (20%) cases required manual removal of placenta. Group B patients (30, 100%) were managed with planned manual removal of placenta. Table IV shows the frequency and types of complications at or after removal of placenta. In Group A, 2 (10%) cases developed PPH and 18 (90%) cases had no complications. In Group B, 6 (20%) cases developed PPH, and 4 (13.33%) cases developed sepsis or endometritis. 
Discussion
This study showed that during the period from January to December 2004 the incidence of retained placenta was 2.05% of total obstetric admission in DMCH. In a study by Chhabra et al 10 in Kasturba Hospital, Delhi, it was found that incidence of retained placenta was 0.23% of all births over 15 years. In their study, out of four deaths two women delivered at nearby district hospital and were referred moribund and died. The policy option was that the properly conducted delivery can reduce the incidence of retained placenta and if removal occurs timely, appropriate care can save life.
Regarding management of retained placenta the present study can be compared with a number of studies. In this study, 16 (80%) patients of Group A, who were managed by intraumbilical vein injection of 10 units oxytocin in 20 mL normal saline, delivered placenta spontaneously with an expulsion time of 7 to 12 minutes after injection and 4 (20%) patients required manual removal. Study done by Golan et al 3 using the same methodology showed that expulsion of placenta occurred in all of their 10 cases a few minutes after intraumbilical injection. The average injection-expulsion time was 2--5 minutes. Using the proposed method of oxytocin injection into the umbilical cord of retained placenta they were able to spare 80% of the patients. A study done in department of Obstetrics and Gynecology, Liverpool Women's Hospital, United Kingdom revealed that women given an intraumbilical oxytocin injection had a significant increase in spontaneous expulsion of placenta within 45 minutes of delivery and fewer manual removal of placenta was needed. The result of their study suggested clinically important beneficial effect of intraumbilical oxytocin injection in the management of retained placenta. 11 These findings are consistent with the present study. In this study, requirement of blood transfusion was less in oxytocin group. This finding correlates with study done by Gajvani et al. 11 A study done by Das SR 12 shows that 23.31% cases needed general anesthesia while removing the placenta manually. In the present study, only 2 (10%) patients in Group A required general anesthesia whereas in Group B, 20 (66.66%) patients required general anesthesia. Patients of Group B required exploration of uterus and had to stay longer in hospital than patients of Group A. In this study complications at or after management of retained placenta with intraumbilical vein injection of oxytocin was less than the non-oxytocin group. Among oxytocin group 18 (90%) cases had no complications and 2 (10%) cases developed PPH. In non-oxytocin group eight patients developed fever and sepsis after manual removal of placenta. The complications were very less in oxytocin group which correlates with the findings of study done by Golan et al. 3 The present study reveals that intraumbilical oxytocin solution is superior to manual removal of placenta. As this study was done in a small number of patients, we recommend that community based study having adequate sample size should be carried out to find out further evidence of efficacy and feasibility of the method in low resource setting.
